Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: 2020 | 2018 | 2017 | 2014
Number of items: 6.

2020

Wimberger, Pauline, Blohmer, Jens U., Krabisch, Petra, Link, Theresa, Just, Marianne, Sinn, Bruno Valentin, Simon, Eike, Solbach, Christine, Fehm, Tanja N., Denkert, Carsten, Kuehn, Cristin, Rhiem, Kerstin, Tesch, Hans, Kuemmel, Sherko, Petzold, Andrea, Stoetzer, Oliver J., Meisel, Cornelia, Kuhlmann, Jan Dominik, Nekljudova, Valentina and Loibl, Sibylle (2020). Influence of denosumab on disseminated tumor cells (DTC) in the bone marrow of breast cancer (BC) patients with neoadjuvant treatment: A GeparX translational substudy. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Wimberger, Pauline, Blohmer, Jens U., Krabisch, Petra, Link, Theresa, Just, Marianne, Sinn, Bruno Valentin, Simon, Eike, Solbach, Christine, Fehm, Tanja N., Denkert, Carsten, Kuehn, Cristin, Rhiem, Kerstin, Tesch, Hans, Kuemmel, Sherko, Petzold, Andrea, Stoetzer, Oliver J., Meisel, Cornelia, Kuhlmann, Jan Dominik, Nekljudova, Valentina and Loibl, Sibylle (2020). Influence of denosumab on disseminated tumor cells (DTC) in the bone marrow of breast cancer (BC) patients with neoadjuvant treatment: A GeparX translational substudy. J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

2018

Loibl, Sibylle, Untch, Michael, Burchardi, Nicole, Huober, Jens Bodo, Blohmer, Jens U., Grischke, Eva-Maria, Furlanetto, Jenny, Tesch, Hans, Hanusch, Claus, Rezai, Mahdi, Jackisch, Christian, Schmitt, Wolfgang D., Von Minckwitz, Gunter, Thomalla, Jorg, Kummel, Sherko, Rautenberg, Beate, Fasching, Peter A., Rhiem, Kerstin, Denkert, Carsten and Schneeweiss, Andreas (2018). Randomized phase II neoadjuvant study (GeparNuevo) to investigate the addition of durvalumab to a taxane-anthracycline containing chemotherapy in triple negative breast cancer (TNBC). J. Clin. Oncol., 36 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

von Waldenfels, Gabriel, Loibl, Sibylle, Furlanetto, Jenny, Anna, Machleidt, Lederer, Bianca, Denkert, Carsten, Hanusch, Claus, Huober, Jens, Jackisch, Christian, Kuemmel, Sherko, von Minckwitz, Gunter, Schneeweiss, Andreas, Untch, Michael, Rhiem, Kerstin, Fasching, Peter A. and Blohmer, Jens U. (2018). Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials. Cancer Res., 78 (4). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445

2017

Hahnen, Eric, Lederer, Bianca ORCID: 0000-0002-4512-2226, Hauke, Jan, Loibl, Sibylle, Kroeber, Sandra, Schneeweiss, Andreas, Denkert, Carsten, Fasching, Peter A., Blohmer, Jens U., Jackisch, Christian, Paepke, Stefan, Gerber, Bernd, Kuemmel, Sherko, Schem, Christian, Neidhardt, Guido, Huober, Jens, Rhiem, Kerstin, Costa, Serban, Altmueller, Janine, Hanusch, Claus, Thiele, Holger, Mueller, Volkmar, Nuernberg, Peter, Karn, Thomas ORCID: 0000-0002-3264-6573, Nekljudova, Valentina, Untch, Michael, von Minckwitz, Gunter and Schmutzler, Rita K. (2017). Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer Secondary Analysis of the GeparSixto Randomized Clinical Trial. JAMA Oncol., 3 (10). S. 1378 - 1386. CHICAGO: AMER MEDICAL ASSOC. ISSN 2374-2445

2014

Von Minckwitz, Gunter, Hahnen, Eric, Fasching, Peter A., Hauke, Jan, Schneeweiss, Andreas, Salat, Christoph, Rezai, Mandi, Blohmer, Jens U., Zahm, Dirk Michael, Jackisch, Christian, Gerber, Bernd, Klare, Peter, Kummel, Sherko, Eidtmann, Holger, Paepke, Stefan, Nekljudova, Valentina, Le Loibl, Sibyl, Untch, Michael and Schmutzler, Rita K. (2014). Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

This list was generated on Fri Apr 19 17:14:18 2024 CEST.